In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells

European Journal of Immunology

Volumn 39, Issue 8, 2009, Pages 2224-2232

  Vavassori, Stefano ^a   Shi, Yufang ^b   Chen, Chiann Chyi ^b   Ron, Yacov ^b   Covey, Lori R ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

CD154; mRNA stability; Polypyrimidine tract binding protein; Post transcriptional regulation

Indexed keywords

CD40 LIGAND; MESSENGER RNA; POLYPYRIMIDINE TRACT BINDING PROTEIN; ANTIGEN; CD28 ANTIGEN; MONOCLONAL ANTIBODY;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA DEGRADATION; RNA STABILITY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; SEQUENCE HOMOLOGY; TIME;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD28; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLYPYRIMIDINE TRACT-BINDING PROTEIN; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TIME FACTORS;

EID: 70249140930     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839163     Document Type: Article

References (41)

1. van Kooten, C., Immune regulation by CD40-CD40-l interactions - 2; Y2K update. Front. Biosci. 2000. 5: D880-693.
2. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., Kooten, C. v., Liu, Y. J. et al., The CD40 antigen and its ligand. Ann. Rev. Immunol. 1994. 12: 881-922.
3. Grewal, I. S. and Flavell, R. A., CD40 and CD154 in cell-mediated immunity. Ann. Rev. Immunol. 1998. 16: 111-135.
4. van Kooten, C. and Banchereau, J., CD40-CD40 ligand. J. Leukoc. Biol. 2000. 67: 2-17.
5. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M. et al., Molecular and biological characterization of a murine ligand for CD40. Nature 1992. 357: 80-82.
6. Castle, B. E., Kishimoto, K., Stearns, C., Brown, M. L. and Kehry, M. R., Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 1993. 151: 1777-1788. (Pubitemid 23235651)
7. Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A. and Noelle, R. J., The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+T cells. J. Immunol. 1993. 151: 2497-2510. (Pubitemid 23264502)
8. de Boer, M., Dasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P. and Ceupens, J. L., Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interkeukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 1993. 23: 3120-3125.
9. Johnson-Leger, C., Christenson, J. R., Holman, M. and Klaus, G. G., Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J. Immunol. 1998. 161: 4618-4626. (Pubitemid 28492035)
10. Peng, X., Remacle, J. E., Kasran, A., Huylebroeck, D. and Ceuppens, J. L., IL-12 up-regulates CD40 ligand (CD154) expression on human T cells. J. Immunol. 1998. 160: 1166-1172. (Pubitemid 28093411)
11. Lee, B. O., Haynes, L., Eaton, S. M., Swain, S. L. and Randall, T. D., The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J. Exp. Med. 2002. 196: 693-704.
12. Lindgren, H., Axcrona, K. and Leanderson, T., Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J. Immunol. 2001. 166: 4578-4585. (Pubitemid 32233743)
13. Parra, E., Mustelin, T., Dohlsten, M. and Mercola, D., Identification of a CD28 response element in the CD40 ligand promoter. J. Immunol. 2001. 166: 2437-2443. (Pubitemid 32173479)
14. Schubert, L. A., Cron, R. Q., Cleary, A. M., Brunner, M., Song, A., Lu, L. S., Jullien, P. et al., AT cell-specific enhancer of the human CD40 ligand gene. J. Biol. Chem. 2002. 277: 7386-7395.
15. Schubert, L. A., King, G., Cron, R. Q., Lewis, D. B., Aruffo, A. and Hollenbaugh, D., The human gp39 promoter. J. Biol. Chem. 1995. 270: 29624-29627.
16. Srahna, M., Remacle, J. E., Annamalai, K., Pype, S., Huylebroeck, D., Boogaerts, M. A. and Vandenberghe, P., NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells. Clin. Exp. Immunol. 2001. 125: 229-236.
17. Tsytsykova, A. V., Tsitsikov, E. N. and Geha, R. S., The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 1996. 271: 3763-3770.
18. Brunner, M., Zhang, M., Genin, A., Ho, I. C. and Cron, R. Q., A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter. Genes Immun. 2008. 9: 640-649.
19. Suarez, A., Mozo, L., AbelGayo ., Zamorano, J. and Gutierrez, C., Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms. Eur. J. Immunol. 1997. 27: 2822-2829.
20. Ford, G. S., Yin, C. H., Barnhart, B., Sztam, K. and Covey, L. R., CD40 ligand exerts differential effects on the expression of Ig transcripts in subclones of an IgM1human B cell lymphoma line. J. Immunol. 1998. 160: 595-605. (Pubitemid 28049298)
21. Rigby, W. F., Waugh, M. G. and Hamilton, B. J., Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes [In Process Citation]. J. Immunol. 1999. 163: 4199-4206.
22. Murakami, K.,Ma, W., Fuleihan, R. and Pober, J. S., Human endothelial cells augment early CD40 ligand expression in activated CD4+T cells through LFA-3-mediated stabilization of mRNA. J. Immunol. 1999. 163: 2667-2673. (Pubitemid 29399191)
23. Ford, G. S., Barnhart, B., Shone, S. and Covey, L. R., Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J. Immunol. 1999. 162: 4037-4044. (Pubitemid 29314786)
24. Hamilton, B. J., Genin, A., Cron, R. Q. and Rigby, W. F., Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol. Cell. Biol. 2003. 23: 510-525.
25. Barnhart, B., Kosinski, P. A.,Wang, Z., Ford, G. S., Kiledjian, M. and Covey, L. R., Identification of a complex that binds to the CD154 3′ untranslated region: implications for a role in message stability during T cell activation. J. Immunol. 2000. 165: 4478-4486. (Pubitemid 30795826)
26. Kosinski, P. A., Laughlin, J., Singh, K. and Covey, L. R., A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J. Immunol. 2003. 170: 979-988. (Pubitemid 36070552)
27. Singh, K., Laughlin, J., Kosinski, P. A. and Covey, L. R., Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J. Immunol. 2004. 173: 976-985. (Pubitemid 38924271)
28. Zhang, T., Kruys, V., Huez, G. and Gueydan, C., AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem. Soc. Trans. 2002. 30: 952-958.
29. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F. et al., Clustal W and Clustal X version 2.0. Bioinformatics 2007. 23: 2947-2948.
30. Yin, D., Zhang, L., Wang, R., Radvanyi, L., Haudenschild, C., Fang, Q., Kehry, M. R. and Shi, Y., Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. J. Immunol. 1999. 163: 4328-4334. (Pubitemid 29474499)
31. Yellin, M. J., Sippel, K., Inghirami, G., Covey, L. R., Lee, J. J., Sinning, J., Clark, E. A. et al., CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. J. Immunol. 1994. 152: 598-608.
32. Soderberg, M., Raffalli-Mathieu, F. and Lang, M. A., Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3′ untranslated region of the murine inducible nitric-oxide synthase mRNA. Mol. Pharmacol. 2002. 62: 423-431.
33. Galban, S., Kuwano, Y., Pullmann, R., Jr., Martindale, J. L., Kim, H. H., Lal, A., Abdelmohsen, K. et al., RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 2008. 28: 93-107.
34. Hamilton, B. J., Wang, X. W., Collins, J., Bloch, D., Bergeron, A., Henry, B., Terry, B. M. et al., Separate cis-trans pathways post- transcriptionally regulate murine CD154 (CD40 ligand) expression: a novel function for CA repeats in the 3′-untranslated region. J. Biol. Chem. 2008. 283: 25606-25616.
35. Guzman-Rojas, L., Sims-Mourtada, J. C., Rangel, R. andMartinez-Valdez, H., Life and death within germinal centres: a double-edged sword. Immunology 2002. 107: 167-175.
36. Erickson, L. D., Durell, B. G., Vogel, L. A., O'Connor, B. P., Cascalho, M., Yasui, T., Kikutani, H. and Noelle, R. J., Short-circuiting long-lived humoral immunity by the heightened engagement of CD40. J. Clin. Invest. 2002. 109: 613-620.
37. Nelson, A. J., Dunn, R. J., Peach, R., Aruffo, A. and Farr, A. G., The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelial cells. Eur. J. Immunol. 1996. 26: 401-408.
38. Dunn, R. J., Luedecker, C. J., Haugen, H. S., Clegg, C. H. and Farr, A. G., Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization. J. Histochem. Cytochem. 1997. 45: 129-141.
39. Clegg, C. H., Rulffes, J. T., Haugen, H. S., Hoggatt, I. H., Aruffo, A., Durham, S. K., Farr, A. G. and Hollenbaugh, D., Thymus dysfunction and chronic inflammatory disease in gp39 transgenicmice. Int. Immunol. 1997. 9: 1111-1122.
40. Porter, J. F., Vavassori, S. and Covey, L. R., A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells. J. Immunol. 2008. 181: 3336-3345.
41. Laughlin, J., Oghlidos, S., Porter, J. F., Matus-Nicodemos, R., Sinquett, F. L., Marcelli, V. and Covey, L. R., Functional analysis of a tripartite stability element within the CD40 ligand 3′ untranslated region. Immunology 2008. 124: 368-379. (Pubitemid 351793469)